Sotera Health Company (SHC)
NASDAQ
Closed
Aug 25, 2026
Day's Range
19.1152 wk Range
13.09Overview - SHC - Sotera Health Company
Key Statistics
Valuation
Enterprise Value
7.38B
P/E (Trailing)
‪34.01‬
P/E (Forward)
‪18.03‬
PEG Ratio
‪0.06‬
Price / Sales (TTM)
‪4.54‬
Price / Book
‪8.31‬
EV / EBITDA
‪12.80‬
Profitability
Gross Margin
‪55.37%‬
Profit Margin
‪13.44%‬
Operating Margin
‪37.95%‬
Return on Assets
‪8.60%‬
Return on Equity
‪27.78%‬
Ownership
Shares Outstanding
285.36M
Float
185.22M
Short % of Shares Outstanding
‪5.82%‬
Held by Insiders
‪2.20%‬
Held by Institutions
‪107.05%‬
Price stats
Beta
‪1.77‬
50-Day Avg
‪17.80‬
200-Day Avg
‪16.66‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
10 analysts
Average price target
‪$ 22.72‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SHC - Sotera Health Company
Peers - SHC - Sotera Health Company
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
Profile Summary - SHC - Sotera Health Company
About
Sotera Health Company is a leading provider of mission-critical health and sterilization services. It plays a vital role in ensuring safety and compliance across medical device, pharmaceutical, food, and other industries that require stringent sterilization and laboratory testing services. The company operates under…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
